Loss of Neutralizing Activity of Tixagevimab/Cilgavimab (Evusheld™) Against Omicron BN.1, a Dominant Circulating Strain Following BA.5 During the Seventh Domestic Outbreak in Korea in Early 2023
2023年初韩国第七次国内疫情爆发期间，Tixagevimab/Cilgavimab (Evusheld™) 对 BA.5 之后的主要流行毒株 Omicron BN.1 的中和活性丧失
期刊:Journal of Korean Medical Science
影响因子:2.3
doi:10.3346/jkms.2023.38.e205
Yang, Jinyoung; Hyeon, Seokhwan; Baek, Jin Yang; Kang, Min Seo; Lee, Keon Young; Lee, Young Ho; Huh, Kyungmin; Cho, Sun Young; Kang, Cheol-In; Chung, Doo Ryeon; Peck, Kyong Ran; Won, Gunho; Lee, Hye Won; Kim, Kwangwook; Hwang, Insu; Lee, So Yeon; Kim, Byung Chul; Lee, Yoo-Kyoung; Ko, Jae-Hoon
